alzheimer

New drug found to slow early Alzheimer’s disease symptoms: Study

by

A new drug has been found to slow cognitive and functional decline in people with early symptomatic Alzheimer’s disease (AD), according to the results of the phase 3 clinical trials. The data about the drug donanemab, developed by American pharmaceutical firm Eli Lilly and Company, was shared at the 2023 Alzheimer’s Association International Conference (AAIC) … Read more

Suven to participate in 11th clinical trials on Alzheimer’s disease in Spain

by

Suven Life Sciences is participating and presenting the baseline patient demographics and scales from the ongoing phase-2a proof-of-concept trial of SUVN-502 for moderate Alzheimer’s Disease at 11th clinical trials on Alzheimer’s disease (CTAD) during October 24-27, 2018 at Barcelona, Spain. SUVN-502 is a promising pure, 5-HT6 receptor antagonist in development for the treatment of moderate … Read more